Table 3.
Response | Terms ▸ | HCV vl | Group* | ||
---|---|---|---|---|---|
| |||||
Model ▾ | Estimate | p | Estimate | p | |
Log10 MFI of CD38 on CD3+CD8+ | 1 | −0.04 | nsᵼ | −0.14 | <0.0001 |
CD4+FoxP3+CD25+ % | 1 | −0.008 | ns | 0.14 | 0.0002 |
MFI of PD1 on CD3+CD8+ | 1 | −1.99 | ns | −3.85 | ns |
MFI of CTLA-4 on CD3+CD8+ | 1 | 2.83 | ns | −11.48 | 0.04 |
MFI of BTLA on CD3+CD8+ | 1 | −11.22 | ns | −23.75 | ns |
MFI of CD160 on CD3+CD8+ | 1 | 0.36 | ns | −8.86 | <0.0001 |
MFI of CD69 on Lin3−CD56dimCD16+ | 1 | −1.65 | ns | −2.78 | 0.04 |
MFI of CD81 on Lin3−CD56dimCD16+ | 1 | 590.17 | 0.02 | −98.78 | ns |
MFI of IFN-αR on Lin3−CD56dimCD16+ | 1 | −5.03 | ns | 39.33 | 0.01 |
Constitutive MFI of p-STAT-1 on Lin3−CD56+CD16+ | 1 | −4.18 | ns | −5.92 | 0.002 |
AUC IFNα-induced - AUC constitutive | 1 | 26.11 | ns | 58.39 | 0.02 |
Log10 (IFNα-induced - constitutive) Lin3−CD56dimCD16+IFN-γ+ % of Lin3−CD56dimCD16+ | 1 | −0.07 | ns | 0.11 | ns |
Log10 (IFN-α-induced - constitutive) Lin3−CD56brightIFN-γ+ % of Lin3−CD56bright | 1 | 0.06 | ns | −0.03 | ns |
Response | Terms ▸ | HCV vl | Group | HCV vl: Group | |||
---|---|---|---|---|---|---|---|
Model ▾ | Estimate | p | Estimate | p | Estimate | p | |
MFI of CD69 on Lin3−CD56dimCD16+ | 2 | −2.04 | ns | −2.7 | ns | −3.93 | 0.03 |
Constitutive MFI of p-STAT-1 on Lin3−CD56+CD16+ | 2 | −3.64 | ns | −6.01 | 0.001 | 4.78 | 0.04 |
Log10 (IFNα-induced - constitutive) Lin3−CD56dimCD16+IFN-γ+ % of Lin3−CD56dimCD16+ | 2 | −0.03 | ns | 0.1 | ns | 0.21 | 0.008 |
Group: HCV mono-infected, HIV/HCV co-infected.
ns: non-significant